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Summary: This report summarizes a one year evaluation of Abbott's ABA 100, with respect to mechanical parts
(syringe plates, precision and linearity of photometry, band width of several filters, multicuvet precision, temperat-
ure control) and the reliability of several methods (endpoint procedures: determination of the glucose concentra-
tion with the hexokinase- and the glucose dehydrogenase method, and of the protein concentration; enzyme
activities: alanine and aspartate aminotransferase, creatine kinase, alkaline phosphatase).
The critical batch size was estimated as an indicator of economy (about 40 samples per day for the glucose con-
centration).
Various aspects of the instrument are discussed with respect to its use in clinical chemistry.
Evaluation des Abbott Bichromatic Analyzer 100
Ein Vorschlag fur ein Evaluations-Schema
Zusammenfassung: Der ABA 100 wurde während eines Jahres bezüglich der Mechanik (Syringe plates, Präzision
und Linearität des Photometers, Bandbreite einiger Filter, Präzision der Multiküvette, Temperaturkontrolle) und
einiger Methoden getestet. Zur analytischen Evaluation wurden 2 Endpunkt-Verfahren (Bestimmung der Glucose-
konzentration mittels der Hexokinase- und der Glucosedehydrogenase-Methode und der Proteinkonzentration) und
4 Enzymaktivitätsbestimmungen (Alanin- und Aspartat-Aminotransferase, Creatinkinase, Alkalische Phosphatase)
ausgewählt.
Als Indikator für die Wirtschaftlichkeit des ABA 100 wurde die kritische Serienlänge für die Glucose-Bestimmung
auf etwa 40 Proben für eine tägliche Serie geschätzt.
Einige Vor- und Nachteile des Gerätes für klinisch-chemische Routinelaboratorien werden diskutiert.
Introduction Materials and Methods
Two years ago the ABA 100, a single channel, discrete The ABA 100 (serial No. 136 A) was set up according to
analyzer, was introduced on the European market after table 1 as recommended by the manufacturer (Abbott GmbH,
it has been successfully distributed in the United States £*236 *»**?$· ™e<Sfseer was instaUed w"h *" ** C0n~
, «, w, j - " VA " · . diuoner (serial No. 73 552).since 1971. We undertook a 12 months evaluation
because of some features which distinguish this instru-
ment from most other analyzers: the use of 2 wave* Glucose
lengths for each determination, of ä polystyrene multi- jest kits were used from Abbott (hexokinase method), from
cuvet and of an interchangeable syringe plate. Boehringer Mannheim (D-6800 Mannheim, hexokinase method;
No. 124346; assay mixture: 200 parts of solution I, 8 parts of
This report contains a nunimum of information which and III, 1.6 parts of IV) and from E. Merck AG (D-6100
should be collected during the .valuation of analyzer,. ^^^^^^^^'^.^
The study follows some recommendations of Broughton > solution, 0.22 mol/l). For comparison the glucose con-
et al. (1). centration was determined with an Eppendorf endpoint
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Tab. 1. Use of the ABA 100 for various methods.
Methods
Glucose
Total protein
γ-glutamyitransferase
o-hydroxybutyrate dehydro-
genase
Lactate dehydrogenase
Alkaline phosphatase
Creatine kinase
Aspartate aminotransf erase
p-nitrophenol
Filter
340/380
550/650
450/415
340/380
340/380
450/415
340/380
340/380
450/415
Temper- Time
ature
[°C]
25
25
25
25
25
25
25
25
25
[min]
5
10
5
5
5
5
5
5
5
Carousel Direction
revolution
2
2
3
3
3
3
3
3
3
up
up
down
down
down
down
down
down
down
Syringe
plate
1:
1:
1:
1:
1:
1:
1:
1:
1:
101
51
51
51
101
101
26
26
101
Mode
Selector
end point
end point
rate
rate
rate
fate
rate
rate
end point
Zero
00.00
000.0
1500
-425
-600
1800
1700
-600
1800
analyzer 5030 (Eppendorf Ger tebau GmbH, D-2000 Ham-
burg) and with a Gemsaec analyzer (Electro-Nucleonics,
D-7000 Stuttgart) as previously described (2, 3).
The recovery of glucose added to various serum samples was
calculated from the results of the following assays:
1. 9.0 ml double distilled H2O + 1.0 ml glucose solution
(10 or 100 mmol/1),
2. 9.0 ml serum + 1.0 ml glucose solution (10 or 100 mmol/1).
3. 9.0 ml serum + 1.0 ml double distilled H2O.
Artificial hemolysis
Blood samples were drawn with heparinized monovettes
(W. Sarstedt, D-5223 Numbrecht-Rommelsdorf) and divided
into 2 halves. One part was frozen (- 50°C) for approx.
20 minutes, thawed in a water bath (+ 37°C), shaken
for 10 minutes (vortex mixer) and then centrifuged
(10 minutes, 4000 rpm, Christ centrifuge Junior III) together
with the untreated other part. The supernatant plasma was
used for the determination of the glucose concentration.
The filter factor was checked for a filter 340/380 nm with
the hexokinase procedure for the determination of the glucose
concentration: 100 mj reaction mixture + 1 ml glucose
standard solution (10 mmol/1); 50 μΐ of the total mixture
were transferred into each cuvet. The "scaling factor" was
set to 05.00 arid "zero" to 00.00; The mean of at last 10
print-out values yields the filter factor.
The calculation of precision within series from duplicates
and from day to day and other statistical tests were per-
formed as described in I.e. (6).
Results
Technical features of the ABA 100 were evaluated
first, followed by methodological aspects, which were
divided into endpoint determinations (e.g. glucose and
protein concentration), and measurements of enzyme
activities.
Protein
Boehringer test combination No. 124290 and biuret reagents
for the SMA 12/60 from Technicon Corp. (D-6368 Bad Vilbel;
method file No. N-14 b). Sample blank values were obtained
with the ABA 100 by using an alkaline iodide solution as
diluent (biuret reagent without CuSC>4 and tartrate).
Enzyme activities
were determined for comparison with Eppendorf analyzers
5010 (Eppendorf Ger tebau GmbH) according to the Recom-
mendations of the German Society of Clinical Chemistry (4).
International units were calculated from 7 absorbance readings
by means of regression analysis (5). Boehringer test combina-
tions were used with the ABA 100, and the following were
used with the Eppendorf analyzer:
Creatine kinase Boehringer test combination No. 124176
alkaline phosphatase Merckotest No. 3314, lactate dehydro-
genase Merckotest No. 3367, alanine aminotransf erase
Merckotest No. 3376, aspartate aminotransferase Merckotest
No. 3375 and rglutamyltransferase Boehringer test combina-
tion No. 124702.
All reagents from test kits were prepared according to the
instructions of the manufacturer.
Bilirubin control, lot No. BIG294 (bilirubin: 19.6 mg/dl,
human albumin: 5.5 g/dl) was purchased from Merz & Dade
(D-8000 M nchen).
The band width of some interference filters was determined
with a spectrophotometer DMR 21 (C. Zeiss, D-7082 Ober-=
kochen). The filters were held by a self-made adapter (slit:
maximal 0.06 mm, scale of registration 0-20%, MT 2-1).
Mechanical evaluation
Syringe plates
The syringe plates are designed to dispense fixed
volumes. They are easily and rapidly interchanged
(10 seconds to turn a screw and to flush the reagent).
The correct volumes are set by the manufacturer. The
precision of the total volume dispensed by various
syringe plates are listed in table 2.
Tab. 2. Precision of syringe plates dispensing sample and diluent
(double distilled water). The temperature was not con-
sidered.
Syringe
plate <
1:201
1:101
1: 51
1: 26
°
sample
• volume
[μΐ]
2.5
5
5
10
diluent
volume
[Ml]
500
500
250
250
X
[mg]
5219b)
493.3
254.4
261.3
259.6
s
[mg]
2
0.3
0.3
0.21
0.4
CV*)
{%}
0.05
0.29
0.11
0.08
0.16
n
10
10
10
10
10
a) coefficient of variation.
b) control serum as sample; in all other cases double distilled
water was used.
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Tab. 3. Measurement of absorbance units with an ABA 100 at 8 days using an alkaline p-nitrophenol solution (560 mg/1 NaOH,
1.0 mol/1).
p-nitrophenol solution dispensed into
the multicuvet with the syringe plate
1:101
Filter 450/514
x*) s CV
500 μΐρ-nitrophenol solution prediluted 1:101 dispensed directly into the
30 chambers of the multicuvet
[absorbance units] \%\
Filter 450/5 14
χ
[absorbance units]
Filter 340/380
CV χ s
[%J [absorbance units]
a) mean value of 30 measurements.
CV
1 508.6
2 497.0
3 504.7
4 488.2
5 503.3
6 515.7
7 501.4
8 523.9
mean 505.4
value
9.06
4.83
5.05
10.68
10.91
7.04
7.23
7.03
1.78
0.97
1.00
2.19
2.17
1.37
1.44
1.34
488.8
485.9
499.7
486.9
498.7
503.5
496.1
507.4
495.9
0.65
1.14
0.74
0.76
0.70
1.01
0.53
0.62
0.13
0.23
0.15
0.16
0.14
0.20
0.11
0.12
382.3
381.6
380.6
394.9
397.6
397.0
400.2
0.72
0.96
0.78
0.83
0.82
1.21
0.58
0.19
0.25
0.20
0.21
0.21
0.30
0.15
For the determination of enzyme activities the volumes
should be dispensed as accurately as possible if the
calculation factor provided by the manufacturer is
applied. The sample volume is too low for exact
weighing. Therefore, the dilution of a coloured solu-
tion was used to get information on precision and
accuracy of the sample pipetting (tab. 3).
The precision of photometry determined with a
p-nitrophenol solution prediluted 1:101 (5 ml precision
pipet, 500 ml volumetric flask) was found to be about
0.16%, and that of the diluting process of a 1:101
syringe plate to be about 1.5 % (tab. 3). The mean
values of both procedures from 30 X 10 measurements
(at 10 days) differed by approximately 2%. Another
1:101 syringe plate was found to be much less accurate.
Therefore, the volume dispensed should be checked by
the customer if accurate volumes are required.
Multicuvette
Absorbance differences between single cuvettes are
corrected by the dual wavelength mode of the ABA
100. Cross variations of the inner diameter (pathway
of the light beam) were not observed (tab. 3).
Temperature control
The temperature control was checked during 2 weeks at
9°° a.m. and 3?° p.m. with a platinum resistance ther-
mometer inserted into the water bath and into single
cuvettes containing 500 μΐ double distilled water. A mean
difference of 0.1 °C between the surrounding water
bath and the inner room cuvettes was observed. The
variations from day to day or between the 2 daily
measurements were within the precision of the thermo-
meter (< 0.1°C). The cooling device consists of a fan
blowing air around the water bath. This system tolerated
a hair dryer positioned in front of the analyzer up to
an air temperature of approximately 30°C (tab. 4). This
is in agreement with the claim of the manufacturer that
the air conditioning unit has a capacity up to 30°C
room temperature.
Photometer
The precision of photometry at 450 and 340 nm can be
judged from table 3. During a period of 12 carousel
revolutions the print-out value of a 5.5 mg/1 p-nitro-
phenol solution in 0.1 mol/1 NaOH (print-out = 0380;
absorbance determined with a Zeiss spectrophotometer
PM 4: A4so nm - 0.1, A4is nm ~ 0.5) drifted 6 digits
per hour. The linearity of the photometer reading
could be followed up to a p-nitrophenol concentration
of 250 μιηοΐ/ΐ at 450/415 nm (fig. 1). This solution
has an absorbance of about 2.5 at 415 nm (Zeiss
photometer PM 4). The band width of several inter-
ference filters which were selected by chance is reported
in table 5. The factors of two 340/380 nm filters were
Tab. 4. The temperature control of the ABA 100 at 25°C under
the influence of a hair dryer positioned in front of the
analyzer. Ten minutes after another temperature was set,
the temperature was measured with 2 thermometers at
cuvette No. 1 and cuvette No. 18 in the surrounding air
and by a platinum resistance thermometer in cuvette
No. 1 and No. 18 filled with 500 μΐ water.
Surrounding air °C
in front of behind
carousel carousel
21.2
27.8
30.4
35.2
37.4
46,4.
18.8
24.4
26.4
28.0
30.6
31.4
Cuvette °C
No. 1 No. 18
24.7
24.6
24.7
25.1
25.7
26.7
24.5
24.6
24.7
25.1
25.7
26.8
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Tab. 5. Optical band width of various interference filters supplied
with an ABA 100.
QO 100 200
p-nitrophenol (jumol/l)
Fig. 1. Linearity of the ABA 100 photometer at 450/415 nm.
found to be 1.5—2% higher than those provided by the
manufacturer: 4.58 (Abbott: 4.65) and 4.86 (Abbott:
4.96).
Analytical evaluation
Glucose
Two methods for the determination of the glucose con-
centration were compared with the ABA 100: the hexo-
kinase and the glucose dehydrogenase procedure (7).
Filter
nm
500
500
600
600
380
380
340
340
band width
nma)
12.0
12.0
12.0
12,0
10.5
10.8
11.5
12.5
maximum of transmission
atnm %
498.5
497.5
601.0
601.5
380.0
381.0
340.0
340.0
13.7
15.9
17.0
13.8
11.6
10.4
18.8
19.2
a) double path through the optical system decreases the band
width by >/£
The instrument was set up in the same way for both
methods (tab. 1). Both methods were linear at least up
to 20 mmol/1 glucose.
The precision from day to day varied between 1.9 and
4.7 % (tab. 6). The means in table 6 correlated suffi-
ciently with the assigned values.
The accuracy was further investigated by comparing
the results from various patients' sera with the ABA 100
and with 2 other analyzers (fig. 2). In the Eppendorf
instrument the supernatant from a deproteinization
with Zn(OH)2 was used; with the Gernsaec serum
samples were directly assayed by a two-point procedure
(3).
The ABA 100 applies a dual-wavelength blanlosubtrac-
tion technique which uses the NADH, or NADPH
Tab. 6. Glucose concentration (mmol/1) found in various control sera with the hexokinase and the glucose dehydrogenase method.
Control serum
(Batch No.)
Seronorm
(126)
(124)
Validate N
(0141014)
Hyland
(V04)
(V01)
Monitrol I
124 A, B
Monitrol II
(32)
(38)
Kontrollogen L
(410)
Asid PKS
(405 A)
Behring-Richtigkeit
(117S)
Regression analysis:
y (experimental data) =
r =
m (pairs of data) =
assigned value
(95 grange)
[mmol/1]
7.5
(7.5-7.8)
6.5
(6.3-6.7)
4.7
(4.4-5.0)
4.6
(4.3-4.9)
12.2
(11.6-12.8)
4.2
(3.6-4.8)
12.6
(11.8-13.4)
11.8
(11.0-12.6)
3.8
(3.4-4.1)
4.9
(4.4-5.4)
5.6
(5.1-6.1)
hexokinase method glucose dehydrogenase method
* CVS (η) χ CVd (η) χ CVS (η) χ CVd
[mmol/1] [%] [mmol/1] [%] [mmol/1] [%} [mmol/1] [95
6.3 1.0
4.9 1.2
12.0 1.0
4.2 1.9
12.3 1.9
3.9 1.8
4.9 0.8
5.6 2.4
7.4 1.9
(15)
(15)
4.6 4.3
(15)
4.2 4.5
(15)
12.6 2.9
(15)
(15) 4.0 2.3
(15) 4.9 2.6
(15) 5.9 3.1
0.9995 x + 0.0451
0.9978
12
(10) .
6.2 1.1
(10)
(9)
(9)
(9) 3.9 1.5
(9) 4.9 0.8
(9) 5.7 0.9
0.9380X + 0
0.9978
7
7.1 3.5
(12)
4.4 4.5
4.1 4.7
12.2 4.1
(12) 3.8 2.7
(11), 4.9 3.4
(11) 5.8 2.8
.3078
(n)
'Λ
(10)
(10)
(9)
(9)
(9)
(9)
(9)
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20.0
iao
16.0
·»
[12,0
3
c1QO
C
I 6,0
6.0
4.0
2.0
0.0 2Ό 4JO 6JO «0 100 1ZO 14.0 16.0 18.0
Glucose (Eppendorf analyzer 5030) [mmol/l]
200
ZO
θ
I I I I
0.0 20 4.0 6JO aO 10.0 1ZO 14.0 16.0 18.0 20.0
Glucose (Eppendorf analyzer 5030) [mmol/l]
ΟΌ 2JO 4vO 60 6LQ 100 12.0 14:0
Glucose (Gemsaec) (mmol/l]
mo mo 2ao
Fig. 2. Comparison of the glucose concentration in samples from
various patients determined with an ABA 100, a Gemsaec
and an Eppendorf analyzer 5030. ABA 100: A, C hexo-
kinase method; Β glucose dehydrogenase method. Eppen-
dorf (A, B) and Gemsaec (C) analyzer: hexokinase
method. Regression analysis: A y = 0.9588x + 0.3363,
r = 0.9931, x = 6.58 ± 3.01, y = 6.64 ± 2.91, n = 157,
paired t-test: 2.259. B y = 0.9888x + 0.1289, r = 0.9950,
χ = 6.78 ± 3.16, y = 6.83 ± 3.14, n = 137, paired t-test:
1..976. C y = l.OOTOx - 0.0557, r = 0.9848,
χ = 8.24 ± 3-21, y = 8.24 ± 3.29, n = 45, paired t-test:
0.026.
absorbance maximum at 340 nm corrected for back-
ground absorbance at 380 nm. Over-pr undercprrection
could produce false results. Therefore, the influence
of hemoglobin, triglycerides and bilirubin on both
glucose methods was investigated.
Gochman et l. (8), using the ABA 100, did not ob-
serve interference in the glucose determination by
hemoglobin. This could be confirmed up to a concen-
tration of about 1 g/1 hemoglobin. With 3 g/1 a slight
underestimation (overcorrection at 380 nm) and with
9_42 g/1 an overestimation of the glucose values was
noticed, which could not be explained. At high concen-
trations of hemoglobin above 50 g/1 the low energy sign
is turned on.
Triglycerides (up to 20 mmol/l) did not interfere signi-
ficantly with the applied glucose determinations (tab. 8).
Glucose added to bilirubin control serum was not com-
pletely recovered (tab. 8). In the sera of patients,
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Tab. 7. The influence of hemolysis on the determination of the
glucose concentration (mmol/1).
Patient
serum
No.
Glucose concentration
without with
hemolysis hemolysis
I II
hemoglobin
II ' 1QO concentration
I g/1
[*]
A) Hexokinase method
1
2
3
4
5
5.47
5.47
5.47
5.47
7.49
5.8
3.0
3.0
5.53
5.57
5.55
5.52
7.26
6.1
4.2
3.6
101
102
101
101
97
105
140
120
0.8
0.7
1.1
0.9
3.0
9.0
42
17
B) Glucose dehydrogenase method
1
2
3
4
5
5.17
5.17
5.17
5.17
7.25
5.1
2.7
2.7
5.21
5.17
5.20
5.11
7.01
5.4
3.2
3.8
101
100
101
99
97
106
119
.141
0.8
0.7
1.1
0.9
3.0
9.0
17
41
Protein
A high precision was obtained when the protein con-
centration was determined with the ABA 100 (tab. 1).
A linear relationship between concentrations and results
exists at least up to 100 g/1 protein.
The correlation between the protein content found in
various control sera and assigned Values is satisfactory
(tab. 10).
The protein concentration was determined in various
human sera with a SMA 12/60 and the ABA 100. With
the Technicon analyzer sample blank values were con-
sidered, but not with the ABA 100. Therefore, the
ABA 100 Values were slightly higher than those with
the SMA 12/60. Both procedures correlated well
(fig. 3).
The dual wavelength principle of the ABA 100 does
not completely eliminate sample blank effects with the
biuret reaction. A sample blank value of about 2 %
(maximum 8 %) was observed with clear serum samples
Tab. 8. Recovery of glucose added to various serum samples. All values are means of at least 2 determinations with the ABA 100.
1 hexokinase method, II glucose dehydrogenase method.
Sample
Lipemic serum No. 1
Lipemic serum No. 2
Bilirubin control**)
Bilirubin control
Bilirubin control
glucose calculated
l + 3a)
mmol/1
I
14.32
6.69
10.62
0.92
9.15
II
13.42
6.41
10.46
0.94
9.08
glucose found
2a}
mmol/1
I
14.35
6.78
10.15
0.72
8.87
II
13.57
6.26
9.95
0.71
8.74
recovery
%
I
100.2
101.3
95.6
78.3
96.9
II
101.1
97.7
95.1
75.5
96.3
concentration of
interfering substance
triglycerides: 3.80 mmol/1
triglycerides: 18.23 mmol/1
bilirubin: 311 μηιοΐ/ΐ
bilirubin: 311 jumol/1
bilirubin: 311 μηιοΙ/1
a) See under methods (recovery experiments). t>) Merz & Dade.
Tab. 9. The influence of bilirubin on the glucose determination
in human sera.
Glucose [mmol/1]
Serum
No.
1
2
3
4
Eppendorf
analyzer 5030
hexokinase
method
4.4*)
4.6
4.9
9.2
ABA 100
hexo-
kinase
method
4.1
4.4
4.8
9.0
ABA 100
Glucose-
dehydrogenase
method
3.8
4.2
4.6
9.0
Bilirubin
[μπιοΐ/ΐ]
218
147
135
180
a) mmol/l, mean value of at least 2 determinations.
slightly lower glucose concentrations were found than
with a deproteinization method (tab. 9). This effect
can be explained as an over-correction of bilirubin
which slightly absorbs at 380 nm.
100.0
80.0
^C
en
Q 60.0
20.0
D 20.0 40.0 60.0
Protein (SMA 12/60) [g/l]
80.0 100.0
Fig. 3. Comparison of the protein concentration in various
human sera determined with an ABA 100 and a SMA
12/60. Reagents for the ABA: Boehringer test combi-
nation No. 124290. Regression analysis:
y = 0.9315 χ + 5.826, r = 0.9262, χ = 69.57, y =* 70.63,
η = 322; paired t-test: t = - 7.26.
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Tab. 10. Precision of the protein determination with the ABA 100.
Control
Serum
(batch No.)
Validate N
0141014
Europa-Kontrolle 1
Hyland
VO3
Europa-Kontrolle II
Hyland
VO1
Seronorm
124
Kontrollogen
410
Monitrol II
38 A, B
Monitrol I
130 A, B
assigned
value
(range)
|g/D
68
(64-72)
65
(60-70)
55
(52-58)
71
(67-75)
61
(57-65)
57
(54-60)
72.5
(69-76)
precision within series
χ s CV
fg/ll 1%1
67.8
65.2
55.0
70.4
64.1
56.4
72.3
0.41
0.71
0.62
0.36
0.37
0.44
0.50
0.6
1.1
1.1
0.5
0.6
0.8
0.7
n
12
13
13
13
13
14
13
precision from day to day
χ s CV
[g/1] {%)
67.9
65.0
55.0
70.3
64.1
56.4
72.4
0.95
0.89
1.00
0.64
0.83
0.66
1.09
1.4
1.4
1.8
0.9
1.3
1.2
1.5
n
21
24
27
27
27
29
29
Regression analysis: y = 0.96x + 2.92, χ (assigned values) = 64.2, y (mean value from day to day) = 64.4; r = 0.98 (n = 14).
Tab. 11. Determination of the protein concentration (g/1) in lipemic and hemolytic sera with the ABA 100. Calibration: with protein
standard solution ORTH 16/17 from Behringwerke. Each value is a mean of 2 determinations.
Serum protein concentration
blank value blank value deviation
' not considered subtracted
[g/U tg/il i%\
concentration of
interfering substance
Serum No. 1
Serum No. 2
Serum No. 3
Serum No. 4
Serum No. 5»)
Serum No. 5
Serum No. 6
Serum No. 6
Bilirubin control*^)
Bilirubin control
Albumin solution
76.4
74.6
82.3
90.2
75.6
69.2
83.7
63.9
112.0
54.9
68.5
67.4
65.2
69.4
74.8
66.0
65.0
69.9
61.6
109.9
54.0
68.3
+ 13
+ 14
+ 19
+ 21
+ 15
+ 6
+ 20
+ 4
+ 2
+ 2
—
triglycerides: 5.25 mmol/1
triglycerides: 5.87 mmol/1
triglycerides: 5.12 mmol/1
triglycerides: 16.17 mmol/1
hemoglobin: 2 g/1
not hemolytic
hemoglobin: 10 g/1
not hemolytic
bilirubin: 335 μτηοΐ/ΐ
bilirubin: 168 /imol/1
albumin: 70 g/1
a) blood samples No. 5-6 were split, one half was centrirugated directly, the other part after artificial hemolysis (see under methods).
b) bilirubin control (Merz & Dade) dissolved in 1.5 ml instead of 3.0 ml double distilled H2O.
and should be considered for very accurate measure-
ments or with lipemic and hemolytic sera (tab.l 1).
Bilirubin did not interfere significantly.
The biuret assay was used to check carry-over effects.
For this purpose 3 samples with 10 g/1 albumin, 3 with
100 g/1 and again 3 with 10 g/1 were consecutively
analyzed, A significant interaction (6) could not be
detected.
Aminotransferase
The activity of both alanine and aspartate aminotrans-
ferase was determined in several control sera and in the
sera of 200 patients with the ABA 100 and the results
were compared with those obtained with an Eppen-
dorf enzyme analyzer 5010. The precision from day to
day ranged from 4 to 9 % above an activity of 15 U/l
(tab. 12). The regression analysis revealed an acceptable
congruence between the data found with the ABA and
the assigned values (tab. 12) or those determined with
the enzyme analyzer 5010 (fig. 4; a similar correlation
was obtained in 16 samples with activity values of up
to 1000 U/l).
Creatine kinase
The creatine kinase was used as an example for the
determination of an enzyme activity with increasing
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Tab. 12. Precision of the determination of enzyme activities in various control sera with the ABA 100.
Control serum
?.) aspartate aminotransferase
Monitrol I
Monitrol II
Kontrollogen L
Hyland VO1
Seronorm
b) alanine aminotransferase
Monitrol I
Monitrol II
Kontrollogen L
Seronorm
Seronorm
c) creatine kinase
Kontrollogen L
Hyland VO1
Hyland V04
Monitrol II
Validate N
(batch No.)
(124)
(32)
(410)
(124)
(124)
(32)
(410)
(126)
(124)
(410)
(32)
(0141014)
assigned value
(range)
[U/ll
13(11-15)
37 (33-41)
25 (22-28)
34 (30-38)
131 (125-137)
15 (13-17)
69 (64-74)
32 (29-35)
55 (50-60)
59 (53-65)
26 (18-34)
180(100-260)
204 (158-250)
100(82-118)
15 (13-17)
precision within series
X CV (n)
IU/1] [%]
39
25
34
124
70
33
60
26
183
206
101
12
2.1
34
2.9
2.6
4.1
3.6
3.0
4.6
1.4
1.7
2.0
8.3
(31)
(32)
(30)
(31)
(30)
(30)
(31)
(31)
(3D
(12)
(31)
(31)
from day to day
χ CV
[U/l] [%]
12
39
25
131
14
68
34
53
26
205
6.9
5.5
4.1
5.4
8.9
6.6
5.9
6.4
7.5
3.7
(n)
(13)
(12)
(12)
(11)
(10)
(11)
(12)
(12)
(15)
(12)
d) hydroxybutyrate dehydrogenase
Validate N
Sero norm
Kontrollogen L
Hyland V01
Hyland VO4
Monitrol I
Monitrol II
e) alkaline phosphatase
Seronorm
Hyland VO4
Hyland VO1
Monitrol II
Monitrol I
(2991103)
(124)
(410)
(124)
(32)
(124)
(32)
(124)
80 (66-94)
239 (216^262)
90 (80-100)
185 (160-210)
68 (58^-78)
92 (75-109)
269 (247-291)
241 (217-265)
63 (52^74)
108 (90-126)
194 (174-214)
65 (51-79)
79
252
92
208
71
87
268
2.4
1.1
3.4
2.2
3.2
3.7
1.9
(14)
(14)
(14)
(14)
(14)
(14)
(14)
78
251
92
208
71
88
285
218
57
115
202
57
5.6
6.8
4.0
6.0
9.1
7.2
7.3
1.7
3.6
2.8
3.8
4.6
(7)
(7)
(7)
(7)
(7)
(7)
(7)
(15)
(15)
(15)
(15)
(15)
Regression analysis (x = assigned values, y = found values): aspartate aminotransferase y = l.Olx-0.51 (x = 41.3, y =41.2),
r_= 0.996; alanine aminotransferase y = l.Olx-0.75 (x = 35.5, y = 35.0, r = 0.999; creatine kinase y = 1.03x^4.14 (x = 95.8,
y = 94.7), r = 0.999; hydroxybutyrate dehydrogenase y = 1.10x-6.57 C* = 146, y = 152), r = 0.998; alkaline phosphatase
y = 0.95x + 1.83 (x = 134, y = 130), r = 0.987.
100.0
= 80.0
I
iΞ 6QO
I 20.0
0.0 20.0 40.0 · 60.0 80JO 100D
Asportote ominotronsferase (Eppendorf analyzer 5010) [U/l]
0.0 20.0 40.0 eao 90.0 100.0
Alq nine ominotrqnsf erase (Eppendorf analyzer 5010) I U/l)
Fig. 4. Comparison of the aminotransferase activities in various human sera determined with an ABA 100_and an Eppendorf enzyme
analyzer 5010. A: aspartate aminotransferase (GOT), regression analysis: y = 0.9743* ^ - 0.0873, x = 17.6, y = 17.1,
r = 0.9853 (n = 202). B: alanine aminotransferase (OPT), regression analysis: y = 1.0009x + 0.0356, x = 17.3, y = 17.4,
r = 0.9877 (h = 196). :
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Fig. 5. Comparison of the creatine kinase activity in various human sera determined with an ABA 100 and a partly mechanized
procedure (Eppendorf No. 5085). Reagents: Boehringer test combination No. 124184. Regression analysis:
A y = 0.9509X + 1.3361, r = 0.9804, χ = 27.2 ± 25.7, y = 27.2 ± 24.9, η = 86. B y = 1.0354x - 1.7273, r = 0.9932,
χ = 75.7 ± 154.5. y = 76.6 ± 161.1, n = 107.
absorbance. The precision from day to day varied from
3.7 to 7.6% (tab. 12). Figure 5 shows the correlation
of several activity values determined in the sera of
patients with the ABA 100 and with a partly
mechanized Eppendorf system 5085.
precision data are listed in table 12. Comparing results
from the sera of patients, the ABA 100 values were
about 7 % higher than those determined with an Eppen-
dorf analyzer 5010 (fig. 6). The same effect was ob-
served with the 7-glutamyltransferase (fig. 7). The
reason for this discrepancy was not investigated.
Lactate and hydroxybutyrate dehydrogenase
The typical mode of operation for the determination
of enzyme activities is to take a first reading after a
5 minute incubation period and then a second reading
after further 5 minutes. The results are calculated
from the difference between both values.
As expected the lactate dehydrogenase activity values
were usually 7 % lower than those determined with an
Eppendorf analyzer 5010, since the reaction is not
recorded under the conditions of a zero order reac-
tion. The fast kinetic reaction mode overcomes this
problem, but it cannot be recommended for routine
purposes; the through-put rate would be 15—30
samples per hour leading to 3 results for each patient,
which then have to be compared.
The activity of the hydroxybutyrate dehydrogenase
can be determined with the ABA 100. Precision data
with several control sera are summarized in table 12.
Alkaline phosphatase
The alkaline phosphatase was chosen for evaluating.
determinations at 450/415 nm with the ABA 100. The
500.0 -
: 400.0 -
8
: 300.0 -
200.0 -
100.0 -
00 100.0 200.0 300,0 400.0 SOOjO
Alkaline Phosphatase (Eppendorf analyzer 5010) t U / U
Fig. 6. Comparison of the alkaline phosphatase activity in
various human sera determined with an ABA 100 and
an Eppendoif analyzer 5010. Reagents: Boehringer test
combination No. 123862 (20 ml solution 1 + 2 ml solution
II). Regression analysis:
y = 1.0392X + 8.4169, χ = 140, y = 154, r = 0.9764
(m = 46 pairs).
J. Qin. Chem. din. Biochem. / Vol. 14,1976 / No. 5
236 Haeckel: Evaluation of the Abbott Bichiomatic Analyzer 100
180.0 -
0.0 30.0 600 900 120,0 1500
y-Glutamyltransferose (Eppendorf analyzer 5010) [U/D
Economical aspects
The critical batch size is a term recently introduced
to indicate the cost-benefit relation of an analyzer in
comparison with a manual or less mechanized analy-
tical system (9, 10). If the number of samples to be
analyzed per day is below the critical batch size %,
the mechanized system is less economical; if it is above
this figure, mechanization is to be preferred. Factors
influencing the critical batch size were discussed in
detail elsewhere (10).
In comparison with other analyzers (9) a relatively
low critical batch size was calculated for the ABA 100
as shown by the example in table 13. If a series of
glucose determinations of more than 40 samples are
daily performed the ABA 100 is more economical
than a manual procedure.
Fig. 7. Comparison of the rglutamyltransferase activity in
various human sera determined with an ABA 100 and
an Eppendorf enzyme analyzer 5010. Reagents: Boeh-
ringer test combination No. 124702. Regression analysis:
y = 1.15x - 0.59, r = 0.99, χ = 33.15 ± 31.15, y = 37.69
± 36.75, η = 54; paired t-test: t = - 4.86 (p < 0.01).
Aspects of subjective judgement
Advantages of general interest may be: a low error
rate (tab. 14); only a few minutes are necessary to
switch from one method to another one (about
Tab. 13. The critical batch size (%) of the ABA 100 in comparison with a manual procedure of the glucose determination. Reagents:
Boehringer test combination No. 124346. For explanation of the calculation steps see Ref. 9 and 10.
manual procedure1) . ABA 100
A) fixed costs
I purchase prize
II 1.5% of I
HI one-way material per series
IV costs for reagents per series
c f=(I + I IX5) : 1500 + III + IV
B) variable costs:
I one-way material per sample
II costs for reagents
III time of analysis ti
(DM)
(DM)
(DM)
(DM)
(DM)
(DM)
(min)
(min)
17554.65
263.32
0.73
0.75
14.06
0.27
0.15
56 (10 samples)4)
289 (100 samples)4)
64345.592)
965.18
0.26
—46.37
0.183)
0.14
28 (29 samples)5)
140 (145 samples)5)
nfc - 40
*) Eppendorf photometer 1101, pump 5260, centrifuge 3200, dispenser 5211, diluter 5232.
2) Eppendorf pipet included.
3) Cost for multicuvet/29 samples.
4) Each series contains 3 blanks, 1 standard and 1 control sample.
5) Each multicuvet contains 1 sample, 1 standard and 1 control sample.
Tab. 14. Technical errors of an ABA 100 during a one-year evaluation period (approximately 500 runs).
Type of error defect part sent Service
to the manufacturer called
1. Filter 380/340: defect
2. Syringe plate 1:101: dilution factor deviated more than 5% from the declared value
3. Syringe plate 1:101: valve defect after a 6 months operation period
4. Carousel overjumped some positions
5. Sample pick-up had to be adjusted
6. During print-out of results the instrument stopped, before all data were received.
This happened 4 times; the cause was not investigated.
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1.5 minutes to interchange the syringe plate and
1 minute for all other operations required to start the
analyzer); the complete pipetting system (syringe
plate) can be stored in a refrigerator; a relatively small
space is required for installation (length 100 cm, depth
60 cm, height 61 cm); and the analyzer is easy to
operate.
The instrument appears very suited for the determi-
nation of substrate concentrations if a one-reagent
procedure can be applied, as e.g. glucose and protein.
Reports on bilirubin ((11), Evelyn-Malloy modification),
cholesterol (12) and triglyceride procedures (13) have
recently been published. Methods requiring 2 reagents
which have to be added separately (determination of
urea with the uiease-Berthelot procedure, or of bilirubin
according to Jendrassik & Grof) or methods with sub-
traction of a blank reaction cannot be performed with
the ABA 100.
A further disadvantage of the ABA 100 is its inability
to measure absolute values of absorbance; these can
f\ 9*7
only be obtained by using -=-r X 0.5 as the calibra-
tion factor. Filter factors (FF) supplied by the manu-
facturer, or determined, or checked by the customer
can be obtained only indirectly by a series of experi-
ments with standard materials.
Enzyme activities are determined by a two-point
measurement of absorbance. This procedure can be
accepted for those enzymes which are most commonly
used in clinical chemistry, except for lactate dehydro-
genase.
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